BMY/SNY say prevalence of Plavix poor metabolizers is 2% of whites, 4% of blacks, and 14% of Chinese: http://finance.yahoo.com/news/Sanofiaventis-and-bw-834498494.html?x=0&.v=1 These figures are lower than some of the numbers that previously appeared in the lay press.